These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14712517)

  • 1. [Suppression of nitric oxide on cytotoxicity of Lomustine in glioma cell line BT- 325].
    Gao RL; Chen ZL
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 32(6):519-24, 528. PubMed ID: 14712517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
    Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
    J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine.
    Stritzelberger J; Distel L; Buslei R; Fietkau R; Putz F
    Clin Transl Oncol; 2018 Apr; 20(4):508-516. PubMed ID: 28825189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple combination of lomustine, temozolomide and irradiation reduces canine glioma cell survival in vitro.
    Fuchs D; Rohrer Bley C; Morandi L; Tonon C; Weyland MS; Nytko KJ
    Vet Med Sci; 2023 Jul; 9(4):1573-1583. PubMed ID: 37365849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrochemical behaviour of anticancer drug lomustine and in situ evaluation of its interaction with DNA.
    de Carvalho PAV; Campelo Lopes I; Silva EHC; Bruzaca EES; Alves HJ; Lima MIS; Tanaka AA
    J Pharm Biomed Anal; 2019 Nov; 176():112786. PubMed ID: 31398506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reirradiation and lomustine in patients with relapsed high-grade gliomas.
    Arcicasa M; Roncadin M; Bidoli E; Dedkov A; Gigante M; Trovò MG
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):789-93. PubMed ID: 10098434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
    Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents.
    Yang JJ; Yin JH; Yang DI
    Neurosci Lett; 2007 May; 418(1):106-10. PubMed ID: 17412510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes.
    Zhang GL; Wang YH; Teng HL; Lin ZB
    World J Gastroenterol; 2001 Jun; 7(3):331-4. PubMed ID: 11819785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomide.
    Sankar A; Thomas DG; Darling JL
    Anticancer Drugs; 1999 Feb; 10(2):179-85. PubMed ID: 10211548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma.
    Amarasingh S; Macleod MR; Whittle IR
    J Neurooncol; 2009 Jan; 91(2):117-25. PubMed ID: 18813876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spin labeled antioxidants protect bacteria against the toxicity of alkylating antitumor drug CCNU.
    Gadjeva V; Lazarova G; Zheleva A
    Toxicol Lett; 2003 Oct; 144(3):289-94. PubMed ID: 12927347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic evaluation of low-grade gliomas in adults before and after treatment with CCNU alone.
    Kaloshi G; Roci E; Rroji A; Ducray F; Petrela M
    J Neurosurg; 2015 Nov; 123(5):1244-6. PubMed ID: 26115464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azelaic acid was sensitizing effect in the chemotherapeutic treatment of several melanoma cell lines.
    Rodriguez-Vicente J; Vicente-Ortega V; Canteras-Jordana
    Pigment Cell Res; 1996 Dec; 9(6):317-25. PubMed ID: 9125756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tumor chemotherapy using a rat glioma model.
    Tamura M; Mennel HD; Zülch KJ
    J Cancer Res Clin Oncol; 1979 May; 94(1):39-46. PubMed ID: 468898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide regulation of interleukin-8 gene expression.
    Villarete LH; Remick DG
    Shock; 1997 Jan; 7(1):29-35. PubMed ID: 8989833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats.
    Bethune CR; Geyer RJ; Spence AM; Ho RJ
    Cancer Res; 2001 May; 61(9):3669-74. PubMed ID: 11325837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of topical CCNU(1-(2-chloroethyl)-3 cyclohexyl 1 nitrosurea) treatment on lipid peroxidation of glial tumours transplanted on rat brain.
    Açikgöz S; Bingol F; offin S; Açikgöz B
    Gen Pharmacol; 1995 Mar; 26(2):437-9. PubMed ID: 7590100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide.
    Watkins DN; Garlepp MJ; Thompson PJ
    Br J Pharmacol; 1997 Aug; 121(7):1482-8. PubMed ID: 9257931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats.
    Bethune C; Blum A; Geyer JR; Silber JR; Ho RJ
    Pharm Res; 1999 Jun; 16(6):896-903. PubMed ID: 10397611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.